文献速递骨软组织肉瘤与黑色素瘤

前哨淋巴结播散程度可量化预测黑色素瘤非前哨淋巴结转移及生存

The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
PubMed 文献 · Eur J Cancer · 2018-01-06

该研究对128例前哨淋巴结阳性后行完整淋巴结清扫的黑色素瘤患者,量化前哨淋巴结和非前哨淋巴结的播散癌细胞密度(DCCD)。发现非前哨淋巴结肿瘤负荷显著低于前哨淋巴结,且DCCD前哨淋巴结与总阳性淋巴结数是独立预后因素;基于DCCD前哨淋巴结和肿瘤厚度的预后模型可替代非前哨淋巴结病理分期。

要点

  • 前哨淋巴结DCCD可量化黑色素瘤播散,并预测非前哨淋巴结受累。
  • DCCD前哨淋巴结和总阳性淋巴结数为独立预后因素。
  • 基于DCCD前哨淋巴结和肿瘤厚度的模型可替代完整淋巴结清扫分期。

核心结论

  • 评估前哨淋巴结的播散癌细胞密度(DCCD)可使因分期目的而行的完整淋巴结清扫变得不再必要。

研究设计与样本

  • 对128例因前哨淋巴结阳性行完整淋巴结清扫的黑色素瘤患者,量化前哨淋巴结和非前哨淋巴结的播散癌细胞密度。
  • 共分析1496个前哨淋巴结和非前哨淋巴结,每半份组织解离为单细胞悬液后免疫细胞化学染色,计算每10^6个淋巴结细胞中的黑色素瘤细胞数(DCCD)。

主要发现

  • 大多数患者存在黑色素瘤播散至非前哨淋巴结,但非前哨淋巴结的肿瘤负荷和阳性淋巴结比例显著低于前哨淋巴结。
  • 前哨淋巴结与非前哨淋巴结播散的关系符合数学函数:DCCD_NSN = DCCD_SN^c / 10^(1-c)(c=0.69;95%CI 0.62-0.76)。
  • 中位随访67个月,多因素Cox回归显示DCCD_SN(p=0.02;HR 1.34,95%CI 1.05-1.71)和病理阳性淋巴结总数(p=0.02;HR 1.53,95%CI 1.07-2.22)是显著风险因素。
  • 基于DCCD_SN和黑色素瘤厚度的预后模型预测结局的准确性,与包含前哨淋巴结和非前哨淋巴结病理信息的模型相当。

临床怎么用

  • 前哨淋巴结阳性黑色素瘤患者可通过量化DCCD_SN评估预后,可能避免为分期而行完整淋巴结清扫。
  • 基于DCCD_SN和肿瘤厚度的预后模型可用于风险分层,指导后续管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Complete lymph node dissection (CLND) after a positive sentinel node (SN) biopsy provides important prognostic information in melanoma patients but has been questioned for therapeutic use recently. We explored whether quantification of the tumour spread to SNs may replace histopathology of non-sentinel nodes (NSNs) for staging purposes. PATIENTS AND METHODS: We quantified melanoma spread in SNs and NSNs in 128 patients undergoing CLND for a positive SN. In addition to routine histopathology, one-half of each of all 1496 SNs and NSNs was disaggregated into a single cell suspension and stained immunocytochemically to determine the number of melanoma cells per 106 lymph node cells, i.e. the disseminated cancer cell density (DCCD). RESULTS: We uncovered melanoma spread to NSNs in the majority of patients; however, the tumour load and the proportion of positive nodes were significantly lower in NSNs than in SNs. The relation between SN and NSN spread could be described by a mathematical function with DCCDNSN = DCCDSNc/101-c (c = 0.69; 95% confidence interval [CI]: 0.62-0.76). At a median follow-up of 67 months, multivariable Cox regression analyses revealed that DCCDSN (p = 0.02; HR 1.34, 95% CI: 1.05-1.71) and the total number of pathologically positive nodes (p = 0.02; HR 1.53, 95% CI: 1.07-2.22) were significant risk factors after controlling for age, gender, thickness of melanoma and ulceration status. A prognostic model based on DCCDSN and melanoma thickness predicted outcome as accurately as a model including pathological information of both SNs and NSNs. CONCLUSION: The assessment of DCCDSN renders CLND for staging purposes unnecessary.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Ulmer A, Dietz K, Werner-Klein M, et al. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival. Eur J Cancer. 2018. PMID: 29316475. doi:10.1016/j.ejca.2017.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。